Laffer Tengler Investments’s Gilead Sciences GILD Stock Holding History

Laffer Tengler Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-45	Closed	-$3.09K	–	249
2024 Q2	$3.09K	Hold	45	–	–	﹤0.01%	356
2024 Q1	$3.3K	Hold	45	–	–	﹤0.01%	358
2023 Q4	$3.65K	Hold	45	–	–	﹤0.01%	337
2023 Q3	$3.37K	Sell	45 -8,700	-99%	-$669K	﹤0.01%	295
2023 Q2	$674K	Buy	8,745 +1,313	+18%	+$105K	0.18%	118
2023 Q1	$617K	Sell	7,432 -1,160	-14%	-$96.1K	0.17%	128
2022 Q4	$738K	Buy	8,592 +1,835	+27%	+$145K	0.21%	110
2022 Q3	$417K	Hold	6,757	–	–	0.15%	130
2022 Q2	$418K	Hold	6,757	–	–	0.15%	130
2022 Q1	$402K	Hold	6,757	–	–	0.12%	146
2021 Q4	$491K	Buy	6,757 +614	+10%	+$42.3K	0.14%	136
2021 Q3	$429K	Buy	6,143 +921	+18%	+$64.7K	0.12%	148
2021 Q2	$360K	Buy	5,222 +3,684	+240%	+$246K	0.13%	123
2021 Q1	$99.4K	Buy	1,538 +307	+25%	+$19.8K	0.04%	230
2020 Q4	$69.7K	Buy	+1,231	New	+$74.3K	0.03%	240

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Laffer Tengler Investments's GILD Position: Q3 2024 in Review

Laffer Tengler Investments sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 45 shares — an estimated $3.09K sold.

Laffer Tengler Investments first reported a position in GILD in Q4 2020 and held it in 15 quarters. The position peaked at $738K in Q4 2022. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Laffer Tengler Investments reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
Laffer Tengler Investments sold 45 Gilead Sciences shares in Q3 2024, an estimated $3.09K.
Laffer Tengler Investments first reported a position in Gilead Sciences in Q4 2020 and held it in 15 quarters.
Laffer Tengler Investments's Gilead Sciences position peaked at $738K in Q4 2022.
1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Laffer Tengler Investments's 13F filing for Q3 2024, filed 4 Nov 2024.